Robert S. Benjamin
The University of Texas MD Anderson Cancer Center · 684 works · 39,132 citations · h-index 110
Top works
- Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion
- Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule
- Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer
- Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria
- Adriamycin (NSC 123127) cardiomyopathy. An overview with determination of risk factors
- A Missense Mutation in KIT Kinase Domain 1 Correlates with Imatinib Resistance in Gastrointestinal Stromal Tumors
- Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033
- Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.
- Adriamycin cardiomyopathy—risk factors
- We Should Desist Using RECIST, at Least in GIST
- Pharmacokinetics and metabolism of adriamycin in man
- Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002
- Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapy
- CT Evaluation of the Response of Gastrointestinal Stromal Tumors After Imatinib Mesylate Treatment: A Quantitative Analysis Correlated with FDG PET Findings
- NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines
- Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer
- A phase II trial of taxol in metastatic melanoma
- Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.
- Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
- Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.